TO:      

 

ALL PRINCIPAL INVESTIGATORS/NURSES/DATA MANAGERS

FROM:

 

REGULATORY AFFAIRS DEPARTMENT

DATE: 

 

NOVEMBER 20, 2019

 RE:        

PROTOCOL NRG-GY018 – Neogenomics Holiday hours

 

Protocol Title:  “A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer”  

 

Study Chair:  Ramez Eskander, M.D., (858) 822-6199; email: reskander@ucsd.edu 

 

 

NeoGenomics Laboratories, the central lab for MMR and PD-L1 IHC testing, will be closed the following days:

 

Thanksgiving Day Nov 28 2019

 

Christmas Day Dec 25 2019

 

New Year’s Eve Dec 31 2019

 

New Year’s Day Jan 01 2020

 

Please schedule your shipments accordingly.

 

 

Twitter
This message was sent to shepardm@nrgoncology.org by NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe from all mailings Unsubscribe | Manage Subscription | Forward Email | Report Abuse